Skip to main content


The market stood at $1,197.5 million in 2019, and it is projected to reach $3,097.4 million by 2030. Various developed and developing countries are improving their healthcare infrastructure by adopting novel screening and diagnostic technologies, such as label-free detection, for accurate results. Additionally, market players are focusing on strategic partnerships and collaborations to amplify the usage of this technology and expand their customer base.


Comments